Longfellow Investment Management Co. LLC Acquires 4,361 Shares of Marsh & McLennan Companies, Inc. $MRSH

Longfellow Investment Management Co. LLC grew its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 25,652.9% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 4,378 shares of the financial services provider’s stock after purchasing an additional 4,361 shares during the period. Longfellow Investment Management Co. LLC’s holdings in Marsh & McLennan Companies were worth $882,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of the stock. Rockland Trust Co. raised its holdings in shares of Marsh & McLennan Companies by 801.6% in the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock valued at $2,433,000 after purchasing an additional 10,734 shares during the last quarter. Vanguard Group Inc. grew its position in Marsh & McLennan Companies by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 46,158,562 shares of the financial services provider’s stock worth $10,092,108,000 after purchasing an additional 837,117 shares in the last quarter. Navera Investment Management Ltd. increased its stake in Marsh & McLennan Companies by 7.0% in the 3rd quarter. Navera Investment Management Ltd. now owns 1,623,960 shares of the financial services provider’s stock valued at $327,303,000 after buying an additional 105,954 shares during the last quarter. Bridges Investment Management Inc. boosted its stake in shares of Marsh & McLennan Companies by 4.4% in the 3rd quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock worth $15,356,000 after buying an additional 3,177 shares during the last quarter. Finally, Allstate Corp bought a new position in shares of Marsh & McLennan Companies in the third quarter valued at approximately $3,742,000. Institutional investors own 87.99% of the company’s stock.

Insider Buying and Selling at Marsh & McLennan Companies

In related news, CEO John Q. Doyle sold 16,655 shares of the business’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $21,411,456.30. The trade was a 12.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

MRSH has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. dropped their price target on Marsh & McLennan Companies from $242.00 to $226.00 and set an “overweight” rating on the stock in a report on Wednesday, January 7th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $200.00 price target on shares of Marsh & McLennan Companies in a report on Friday, January 30th. Citigroup increased their price target on shares of Marsh & McLennan Companies from $201.00 to $205.00 and gave the company a “neutral” rating in a research report on Tuesday, February 3rd. Raymond James Financial raised shares of Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price objective on the stock in a research report on Tuesday, February 17th. Finally, Barclays increased their target price on shares of Marsh & McLennan Companies from $206.00 to $210.00 and gave the company an “overweight” rating in a research report on Thursday, January 8th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Marsh & McLennan Companies presently has a consensus rating of “Hold” and a consensus target price of $216.18.

Marsh & McLennan Companies Stock Down 0.0%

NYSE MRSH opened at $184.91 on Friday. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 1.20. The stock has a market cap of $89.52 billion, a price-to-earnings ratio of 21.93, a price-to-earnings-growth ratio of 2.51 and a beta of 0.74. Marsh & McLennan Companies, Inc. has a 52 week low of $170.37 and a 52 week high of $248.00.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings results on Thursday, January 29th. The financial services provider reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.97 by $0.15. The company had revenue of $6.60 billion for the quarter, compared to analyst estimates of $6.52 billion. Marsh & McLennan Companies had a net margin of 15.42% and a return on equity of 31.60%. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.87 earnings per share. As a group, research analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current fiscal year.

Marsh & McLennan Companies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Thursday, April 9th will be given a dividend of $0.90 per share. The ex-dividend date is Thursday, April 9th. This represents a $3.60 annualized dividend and a dividend yield of 1.9%. Marsh & McLennan Companies’s dividend payout ratio is currently 42.70%.

Key Marsh & McLennan Companies News

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Recent quarterly results and a new dividend reinforce fundamentals: MMCo reported an earnings beat and revenue growth, and the company declared a $0.90 quarterly dividend (ex-dividend April 9, payable May 15), which supports income-oriented demand. John Doyle Sells 16,655 Shares of Marsh & McLennan Companies (NYSE:MRSH) Stock
• Positive Sentiment: Analyst coverage is mixed-to-favorable: some firms maintained or raised targets (including a Raymond James upgrade) and consensus price targets remain above the current level, which can underpin buying interest. Analysts Set Marsh (NYSE:MRSH) Target Price at $207.38
• Neutral Sentiment: Market write-ups and peer comparisons continue to circulate (analyst notes / comparison pieces) but don’t introduce new company-specific catalysts; they provide context for relative valuation and may influence longer-term flows rather than intraday moves. Comparing Marsh & McLennan Companies (NYSE:MRSH) & Health In Tech (NASDAQ:HIT)
• Negative Sentiment: CEO John Q. Doyle sold 16,655 shares (~$3.05M at ~$183.30), reducing his stake by ~12.5%. Insider selling can weigh on sentiment because it may be interpreted as reduced insider conviction or a signal of liquidity needs. John Doyle Sells 16,655 Shares of Marsh & McLennan Companies (NYSE:MRSH) Stock
• Negative Sentiment: Legal risk: a Bloomberg Law ruling requires Marsh & McLennan to face a fiduciary-breach case tied to health-plan management — this introduces litigation risk and potential remediation costs that can cap valuation multiple until resolved. Marsh & McLennan Must Face Health Plan Fiduciary Breach Case

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.